BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18628356)

  • 61. Functional loss of tumor suppressor genes detected by loss of heterozygosity, but not driver mutations, predicts aggressive lymph node status in papillary thyroid carcinoma.
    Finkelstein S; Timmaraju VA; Samankan S; O'Malley Q; Kapustin D; Spaulding S; Xing M; Matloob A; Beute J; Seo G; Saturno M; Greenberg L; Wein L; Gonzalez-Velazquez C; Doyle S; Levine J; Urken M; Brandwein-Weber M
    Pathol Res Pract; 2023 Nov; 251():154842. PubMed ID: 37890270
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis.
    Piana S; Ragazzi M; Tallini G; de Biase D; Ciarrocchi A; Frasoldati A; Rosai J
    Hum Pathol; 2013 Apr; 44(4):556-65. PubMed ID: 23079204
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Application of BRAF in the diagnosis and treatment of thyroid papillary carcinoma].
    Zou T; Pan Y; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):629-634. PubMed ID: 34289553
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.
    Niemeier LA; Kuffner Akatsu H; Song C; Carty SE; Hodak SP; Yip L; Ferris RL; Tseng GC; Seethala RR; Lebeau SO; Stang MT; Coyne C; Johnson JT; Stewart AF; Nikiforov YE
    Cancer; 2012 Apr; 118(8):2069-77. PubMed ID: 21882177
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Significance of loss of heterozygosity in predicting axillary lymph node metastasis of invasive ductal carcinoma of the breast.
    Lin X; Zhu B; Finkelstein SD; Saad RS; Snitchler A; Silverman JF
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):116-23. PubMed ID: 22553811
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Xia M; Li H; Ma Q; Yu D; Li J; Zhang Y; Sheng Y; Guo Y
    Cancer Lett; 2017 Jun; 396():110-116. PubMed ID: 28315434
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms.
    Filie AC; Chiesa A; Bryant BR; Merino MJ; Sobel ME; Abati A
    Cancer; 1999 Aug; 87(4):238-42. PubMed ID: 10455213
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants.
    Lam AK; Lo CY; Lam KS
    Endocr Pathol; 2005; 16(4):323-30. PubMed ID: 16627919
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases.
    Le Pennec S; Konopka T; Gacquer D; Fimereli D; Tarabichi M; Tomás G; Savagner F; Decaussin-Petrucci M; Trésallet C; Andry G; Larsimont D; Detours V; Maenhaut C
    Endocr Relat Cancer; 2015 Apr; 22(2):205-16. PubMed ID: 25691441
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel chromosomal translocation t(3;5)(q12;p15.3) and loss of heterozygosity on chromosome 22 in a multifocal follicular variant of papillary thyroid carcinoma presenting with skin metastases.
    Smit JW; Van Zelderen-Bhola S; Merx R; De Leeuw W; Wessels H; Vink R; Morreau H
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):543-8. PubMed ID: 11678839
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing.
    Fang Y; Ma X; Zeng J; Jin Y; Hu Y; Wang J; Liu R; Cao C
    Cell Physiol Biochem; 2018; 50(1):169-178. PubMed ID: 30278442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Screening of selected genomic areas potentially involved in thyroid neoplasms.
    Oriola J; Halperin I; Mallofré C; Muntané J; Angel M; Rivera-Fillat F
    Eur J Cancer; 2001 Dec; 37(18):2470-4. PubMed ID: 11720845
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpression.
    Abrosimov A; Saenko V; Meirmanov S; Nakashima M; Rogounovitch T; Shkurko O; Lushnikov E; Mitsutake N; Namba H; Yamashita S
    Endocr Pathol; 2007; 18(2):68-75. PubMed ID: 17916995
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytogenetic study of a papillary thyroid carcinoma with a rearranged chromosome 10.
    Herrmann ME; Mohamed A; Talpos G; Wolman SR
    Cancer Genet Cytogenet; 1991 Dec; 57(2):209-17. PubMed ID: 1756500
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinoma.
    Kadota M; Tamaki Y; Sakita I; Komoike Y; Miyazaki M; Ooka M; Masuda N; Fujiwara Y; Ohnishi T; Tomita N; Sekimoto M; Ohue M; Ikeda T; Kobayashi T; Horii A; Monden M
    Oncol Rep; 2000; 7(3):529-33. PubMed ID: 10767363
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature.
    Kuhn E; Teller L; Piana S; Rosai J; Merino MJ
    Endocr Pathol; 2012 Jun; 23(2):101-7. PubMed ID: 22434481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Papillary thyroid microcarcinoma: a painstaking category to manage.
    Rossi ED; Martini M; Fadda G; Larocca LM
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):785-6. PubMed ID: 24506451
    [No Abstract]   [Full Text] [Related]  

  • 78. Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors.
    Ng SC; Kuo SF; Chen ST; Hsueh C; Huang BY; Lin JD
    Int J Endocrinol; 2017; 2017():4208178. PubMed ID: 28642790
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The clonal origin of multifocal papillary thyroid cancer: intrathyroidal spread or independent tumors?
    Muzza M
    Minerva Endocrinol (Torino); 2021 Mar; 46(1):35-44. PubMed ID: 33045819
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular cloning of PTC, a new oncogene found activated in human thyroid papillary carcinomas and their lymph node metastases.
    Grieco M; Santoro M; Berlingieri MT; Donghi R; Pierotti MA; Della Porta G; Fusco A; Vecchio G
    Ann N Y Acad Sci; 1988; 551():380-1. PubMed ID: 3245676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.